Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 09 Jun 2026 for Xenon Pharmaceuticals Inc., €39k.
Filing timeline
BuySaleGillian Cannon
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Gillian Cannon: trading record in brief
Gillian Cannon is a declared insider of Xenon Pharmaceuticals Inc., with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 8 August 2023 and the latest from 5 June 2026.
On the market, this insider has only sold: 1 sale, €39k in total. Other entries cover 1 share grant and 3 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
The record was last updated on 9 June 2026 with an open-market sale (€39k) in Xenon Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gillian Cannon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
1,190 shares@ CA$53.140.0008% mcap100.0% of flowCommon SharesTSXSEDI:4732724
1,593 sharesRestricted Share UnitsTSXSEDI:4730355
10,507 sharesOptionsTSXSEDI:4730353
2,645 sharesCommon SharesTSXSEDI:4730346
Common SharesTSXSEDI:4730343
2,645 sharesRestricted Share UnitsTSXSEDI:4730339
6 of 6 declarations
